Search Results - "JONAT, W"

Is the Ki-67 labelling index ready for clinical use? by Jonat, W., Arnold, N.

Get full text

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel by Aapro, M., Abrahamsson, P.A., Body, J.J., Coleman, R.E., Colomer, R., Costa, L., Crinò, L., Dirix, L., Gnant, M., Gralow, J., Hadji, P., Hortobagyi, G.N., Jonat, W., Lipton, A., Monnier, A., Paterson, A.H.G., Rizzoli, R., Saad, F., Thürlimann, B.

“…Bisphosphonates (BP) prevent, reduce, and delay cancer-related skeletal complications in patients, and have substantially decreased the prevalence of such…”
Get full text

Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer by Jonat, W., Bachelot, T., Ruhstaller, T., Kuss, I., Reimann, U., Robertson, J.F.R.

“…The progesterone-receptor (PR) antagonists onapristone (type I) and mifepristone (type II) showed modest activity in hormone-receptor-positive breast cancer;…”
Get full text

Impact of radical operative treatment on the quality of life in women with vulvar cancer – A retrospective study by Günther, V, Malchow, B, Schubert, M, Andresen, L, Jochens, A, Jonat, W, Mundhenke, C, Alkatout, I

“…Abstract Objectives For patients undergoing vulva surgery the quality of life (QoL) is generally accepted as an important outcome parameter in addition to…”
Get full text

Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study by JONAT, W, KAUFMANN, M, EIERMANN, W, SZAKOLCZAI, I, PALMER, M, SCHUMACHER, M, GEBERTH, M, LISBOA, B, SAUERBREI, W, BLARNEY, R, CUZICK, J, NAMER, M, FOGELMAN, I, DE HAES, J. C, DE MATTEIS, A, STEWART, A

“…Current adjuvant therapies have improved survival for premenopausal patients with breast cancer but may have short-term toxic effects and long-term effects…”
Get full text

Breast ultrasound elastography—Results of 193 breast lesions in a prospective study with histopathologic correlation by Schaefer, F.K.W, Heer, I, Schaefer, P.J, Mundhenke, C, Osterholz, S, Order, B.M, Hofheinz, N, Hedderich, J, Heller, M, Jonat, W, Schreer, I

“…Abstract Purpose To evaluate the diagnostic performance of ultrasound elastography in breast masses. Material and methods 193 lesions (129 benign, 64…”
Get full text

The sequential use of endocrine treatment for advanced breast cancer: where are we? by Barrios, C., Forbes, J.F., Jonat, W., Conte, P., Gradishar, W., Buzdar, A., Gelmon, K., Gnant, M., Bonneterre, J., Toi, M., Hudis, C., Robertson, J.F.R.

“…Hormone receptor-positive advanced breast cancer is an increasing health burden. Although endocrine therapies are recognised as the most beneficial treatments…”
Get full text

Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy by Reichardt, P., von Minckwitz, G., Thuss-Patience, P. C., Jonat, W., Kölbl, H., Jänicke, F., Kieback, D. G., Kuhn, W., Schindler, A. E, Mohrmann, S., Kaufmann, M., Lück, H. J.

“…Background: Capecitabine is a rationally designed oral, tumor-activated fluoropyrimidine carbamate with high activity in metastatic breast cancer. This…”
Get full text

Is granulocyte colony-stimulating factor level predictive for human IVF outcome? by Salmassi, A., Schmutzler, A.G., Schaefer, S., Koch, K., Hedderich, J., Jonat, W., Mettler, L.

“…BACKGROUND: We investigated granulocyte colony-stimulating factor (G-CSF) in human reproduction. METHODS: From a total sample of 93 patients, we analysed in…”
Get full text

Influence of additional breast ultrasound on cancer detection in a cohort study for quality assurance in breast diagnosis—analysis of 102,577 diagnostic procedures by Schaefer, Fritz K. W., Waldmann, A., Katalinic, A., Wefelnberg, C., Heller, M., Jonat, W., Schreer, I.

“…Purpose To determine the value of a breast ultrasound (US) examination in addition to mammography in cases of American College of Radiology (ACR) tissue…”
Get full text

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer by Stemmler, H J, diGioia, D, Freier, W, Tessen, H W, Gitsch, G, Jonat, W, Brugger, W, Kettner, E, Abenhardt, W, Tesch, H, Hurtz, H J, Rösel, S, Brudler, O, Heinemann, V

“…Background: An increasing proportion of patients are exposed to anthracyclines and/or taxanes in the adjuvant or neoadjuvant setting. Re-exposure in the…”
Get full text

Interdisciplinary Diagnosis and Treatment of Deep Infiltrating Endometriosis by Alkatout, I, Egberts, J-H, Mettler, L, Doniec, M, Wedel, T, Jünemann, K-P, Becker, T, Jonat, W, Schollmeyer, T

“…Endometriosis is the second most common benign female genital disease after uterine myoma. This review discusses the interdisciplinary approach to the…”
Get more information

One year of experience working with the aid of a robotic assistant (the voice-controlled optic holder AESOP) in gynaecological endoscopic surgery by Mettler, L, Ibrahim, M, Jonat, W

“…The aim of the study was a comparison of robotic versus human laparoscopic camera control. Utilizing robotic technology a robot has been designed specifically…”
Get full text

O449 ENDOSCOPIC MYOMECTOMIES AND OBSTETRICAL OUTCOME by Mettler, L., Schollmeyer, T., Jonat, W., Alkatout, I.

Get full text

Interventional bleeding, hematoma and scar-formation after vacuum-biopsy under stereotactic guidance: Mammotome® -system 11g/8g vs. ATEC® -system 12g/9g by Schaefer, F.K.W, Order, B.M, Eckmann-Scholz, C, Strauss, A, Hilpert, F, Kroj, K, Biernath-Wüpping, J, Heller, M, Jonat, W, Schaefer, P.J

“…Abstract Purpose To evaluate prospectively the correlation of scar-formations after vacuum-assisted biopsy with different systems and needle-sizes and…”
Get full text

Survival analyses from the ZEBRA study: goserelin (Zoladex™) versus CMF in premenopausal women with node-positive breast cancer by Kaufmann, M., Jonat, W., Blamey, R., Cuzick, J., Namer, M., Fogelman, I., de Haes, J.C., Schumacher, M., Sauerbrei, W.

“…The Zoladex Early Breast Cancer Research Association (ZEBRA) trial compared the efficacy and tolerability of goserelin (Zoladex™) with cyclophosphamide,…”
Get full text

Role of LHRH agonists in premenopausal women with oestrogen receptor-positive breast cancer: the ZEBRA experience by Jonat, W

Get full text

Comparison of c-DNA microarray analysis of gene expression between eutopic endometrium and ectopic endometrium (endometriosis) by Mettler, L, Salmassi, A, Schollmeyer, T, Schmutzler, A G, Püngel, F, Jonat, W

“…As recent studies have suggested abnormalities in the regulation of specific genes in the development of endometriosis, we investigated differentially…”
Get full text

Quality of Life in Goserelin-Treated Versus Cyclophosphamide + Methotrexate + Fluorouracil–Treated Premenopausal and Perimenopausal Patients With Node-Positive, Early Breast Cancer: The Zoladex Early Breast Cancer Research Association Trialists Group by DE HAES, H, OLSCHEWSKI, M, KAUFMANN, M, SCHUMACHER, M, JONAT, W, SAUERBREI, W

“…To compare quality of life (QoL) in premenopausal and perimenopausal patients with node-positive, early breast cancer treated with the endocrine agent…”
Get full text

Luteinizing hormone-releasing hormone analogues--the rationale for adjuvant use in premenopausal women with early breast cancer by Jonat, W

“…Current standard adjuvant therapies for early breast cancer include tamoxifen and chemotherapy, depending on the disease prognosis and menopausal status…”
Get full text